INTEGRATED BIOPHARMA INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Integrated Biopharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $259K.
  • Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $430K.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2024 was $112K.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$34K, a 101% decline from 2022.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2022 was $3.84M, a 52.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $430K $259K +$318K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $112K $268K +$228K +570% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-20
Q1 2024 -$116K $285K +$269K +1681% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$385K -$382K -$327K -595% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-10
Q3 2023 -$58K -$59K -$24K -68.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$34K $40K -$1.45M -97.3% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-20
Q1 2023 $1.42M $16K -$781K -98% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $2.2M -$55K -$1.09M -105% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-10
Q3 2022 $3.29M -$35K -$551K -107% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-10
Q2 2022 $3.84M $1.49M -$3.01M -66.9% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 $6.85M $797K -$444K -35.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.3M $1.03M -$193K -15.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-11
Q3 2021 $7.49M $516K -$525K -50.4% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-11
Q2 2021 $8.01M $4.51M +$2.61M +137% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 $5.41M $1.24M +$305K +32.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $5.1M $1.22M +$265K +27.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-05-12
Q3 2020 $4.84M $1.04M +$729K +234% Jul 1, 2020 Sep 30, 2020 10-Q 2022-05-12
Q2 2020 $4.11M $1.9M +$1.54M +428% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 $2.57M $936K +$13K +1.41% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.55M $959K +$713K +290% Oct 1, 2019 Dec 31, 2019 10-Q 2021-05-13
Q3 2019 $1.84M $312K +$153K +96.2% Jul 1, 2019 Sep 30, 2019 10-Q 2021-05-13
Q2 2019 $1.69M $360K -$458K -56% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 $2.15M $923K +$535K +138% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.61M $246K +$594K Oct 1, 2018 Dec 31, 2018 10-Q 2020-05-13
Q3 2018 $1.02M $159K +$338K Jul 1, 2018 Sep 30, 2018 10-Q 2020-05-13
Q2 2018 $679K $818K Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 $388K +$150K +63% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$348K -$271K -352% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-15
Q3 2017 -$179K -$828K -128% Jul 1, 2017 Sep 30, 2017 10-Q 2019-05-15
Q1 2017 $238K +$205K +621% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$77K -$14K -22.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $649K +$408K +169% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 $102K $33K +$139K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$37K -$63K -$610K -112% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $573K $241K -$162K -40.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $735K -$109K +$5K +4.39% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 $730K -$106K +$344K +76.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $386K $547K +$150K +37.8% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 $236K $403K +$105K +35.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $131K -$114K -$894K -115% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 $1.03M -$450K +$82K +15.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $943K $397K -$420K -51.4% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $1.36M $298K +$1.27M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $93K $780K +$2.33M Apr 1, 2013 Jun 30, 2013 10-K 2014-09-08
Q1 2013 -$2.24M -$532K +$206K +27.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$2.45M $817K +$1.6M Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q3 2012 -$4.05M -$972K -$1.34M -368% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2.71M -$1.55M -$572K -58.3% Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 -$2.14M -$738K +$138K +15.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$2.28M -$785K -$362K -85.6% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 -$1.92M $363K +$364K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$2.28M -$981K Apr 1, 2011 Jun 30, 2011 10-K 2012-10-15
Q1 2011 -$876K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$423K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
Q3 2010 -$1K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.